Novartis | DEBITO

Debt Cambiamento Data
AstraZeneca USD 28.58B 1.26B 2023-09
Canopy Growth CAD 681.19M 453.77M 2023-09
Corcept Therapeutics USD 0 0 2022-06
Gilead Sciences USD 24.98B 264M 2023-09
Pacira USD 522.44M 2.14M 2023-12
Perrigo USD 4.09B 7.7M 2023-09
Prestige Brands USD 1.2B 64.34M 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Supernus Pharmaceuticals USD 480.86M 78.9M 2023-03



Novartis DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.